Abstract:Signaling through G protein coupled receptors (GPCRs) is highly regulated and shaped not only by how and when a GPCR engages its ligand, but also through complex and varied protein interactions at the level of the receptor and at downstream effectors. Opioid receptors are an excellent example of a GPCR system that is finely regulated in the central nervous system. The mu opioid receptor is the primary receptor that modulates acute pain responses and has been heavily targeted therapeutically for its anti‐nociceptive properties. The duration and extent of endogenous MOR signaling is modulated by available endogenous opioid peptides, by β‐arrrestin recruitment and subsequent receptor desensitization, by regulator of G protein signaling (RGS) control of Gαo activation, and by interaction with other GPCRs that may positively or negatively alter signaling. Using an unbiased forward genetic screen in MOR‐expressing c. elegans, we uncovered another possible regulator of MOR signaling: the orphan GPCR GPR139. Studies using GPR139 knockout mice demonstrate hypersensitivity to opioid analgesics across multiple measures of antinociception. However, the exact molecular mechanism(s) of how GPR139 activation and signaling can modulate MOR downstream signaling is unknown. We ran a battery of in vitro signaling assays to determine how GPR139 signals in cells and how that could negatively modulate MOR signaling. GPR139 G protein coupling was tested using every G alpha protein and was found to couple to both Gq/11 and Gi/o family of G proteins. We examined the effect of GPR139 on multiple parameters of MOR signaling and trafficking and found that GPR139‐Gq signals in an opposing manner to MOR‐Go signaling at multiple downstream effectors in vitro. Further, MOR‐mediated changes in habenular neuron firing are blunted by dynamic GPR139 activation and can be rescued by Gαq inhibition. Overall, this research examines the molecular underpinnings of GPR139 negative regulation of MOR, explores mechanisms of GPCR cross‐regulation, and evaluates the possibility of therapeutically targeting GPR139 to increase the safety and efficacy of opioids.

Selective optogenetic inhibition of Gαq or Gαi signaling by minimal RGS domains disrupts circuit functionality and circuit formation

A neuropsin-based optogenetic tool for precise control of Gq signaling

AGS3-based optogenetic GDI induces GPCR-independent Gβγ signaling and macrophage migration

Interrogating the function of GABAA receptors in the brain with optogenetic pharmacology

Optogenetic inhibition quenches the integration of sensory input in the cortex

Optogenetic Engineering to Probe the Molecular Choreography of STIM1-mediated Cell Signaling

A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits

Optogenetic control of a GEF of RhoA uncovers a signaling switch from retraction to protrusion

Modulation of the zebrafish optokinetic reflex by pharmacologic agents targeting GABAA receptors

High-efficiency optogenetic silencing with soma-targeted anion-conducting channelrhodopsins

Engineered mini-G proteins block the internalization of cognate GPCRs and disrupt downstream intracellular signaling

Spatiotemporal Control of GPR37 Signaling and Its Behavioral Effects by Optogenetics

Optogenetic elevation of postsynaptic cGMP in the hippocampal dentate gyrus enhances LTP and modifies mouse behaviors

GPR139 Signals Through Gq/11 to Oppose Mu Opioid Receptor Signaling

Specific and behaviorally consequential astrocyte Gq GPCR signaling attenuation in vivo with iβARK

Engineering GPCR signaling pathways with RASSLs

Spatiotemporal limits of optogenetic manipulations in cortical circuits

Modulation of Basal and Receptor-Induced GIRK Potassium Channel Activity and Neuronal Excitability by the Mammalian PINS Homolog LGN

A photoswitchable GPCR-based opsin for presynaptic inhibition

Neuronal Gα Subunits Required for the Control of Response to Polystyrene Nanoparticles in the Range of Μg/l in C. Elegans

Selective Manipulation of Spinal Microglia by Chemogenetics: Implications for Allodynia and Inflammatory Signaling